Global Congestive Heart Failure Treatment Devices Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Congestive Heart Failure Treatment Devices Market was valued at $23.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 7.2% CAGR, to an estimated market size of $33.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global congestive heart failure (CHF) treatment devices market includes medical technologies designed to manage, monitor, and treat heart failure, specifically focusing on mechanical circulatory support (such as ventricular assist devices) and cardiac rhythm management (including ICDs, CRT systems, and pacemakers). The scope excludes general pharmaceutical treatments and non-specific surgical tools.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Congestive Heart Failure Treatment Devices Market in the period 2025-30:
- The rapidly aging global population is the primary driver, as heart failure prevalence increases significantly in individuals over the age of 65.
- There is a significant shift toward third-generation continuous-flow VADs which offer improved hemocompatibility and lower complication rates for long-term care.
- The integration of AI-based remote monitoring platforms is becoming a competitive necessity for device manufacturers to improve outpatient management.
- Technological miniaturization is leading to the development of leadless CRT and smaller, more efficient ICD generators that reduce surgical invasiveness.
- The rising prevalence of comorbidities such as diabetes, obesity, and hypertension is expanding the patient pool requiring mechanical cardiac support.
- Market growth in emerging economies is currently restrained by high device costs and a lack of favorable reimbursement policies for advanced cardiac technologies.
- A growing preference for destination therapy over bridge-to-transplant is increasing the long-term utilization of ventricular assist devices.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Implantable Cardioverter Defibrillators (ICDs)
- Ventricular Assist Devices (VADs)
- Cardiac Resynchronization Therapy (CRT)
- Pacemakers & Other Devices